Alain Nhamias
8Patents
3h-index
8Co-inventors
46Inventor score
Filing activity: Aug 9, 2002 → Mar 17, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8927028B2 | Pharmaceutical composition containing coated, floating particles | Human Necessities | 25 | Active |
| US8003690B2 | Topical nanoparticulate spironolactone formulation | Human Necessities | 5 | Active |
| US9849097B2 | Dosage forms containing terbutaline sulphate | Human Necessities | 3 | Active |
| US9622980B2 | Controlled release compositions | Emerging Cross-Sectional Technologies | 3 | Active |
| US9101544B2 | Controlled release nisoldipine compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US9314430B2 | Floating gastric retentive dosage form | Human Necessities | 1 | Active |
| US10076500B2 | Floating gastric retentive dosage form | Human Necessities | 0 | Active |
| US8663693B2 | Nanoparticulate formulations of fenofibrate | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.